Like melatonin, agomelatine (S20098) increases the amplitude of oscillations of two clock outputs: melatonin and temperature rhythms

References

• Armstrong SM, McNulty OM, Guardiola-Lemaitre B, Redman JR. (1993). Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS). Pharmacol Biochem Behav. 46:45–9
   PubMed Web of Science ®Google Scholar
• Azekawa T, Sano A, Aoi K, et al. (1990). Concurrent on-line sampling of melatonin in pineal microdialysates from conscious rat and its analysis by high-performance liquid chromatography with electrochemical detection. J Chromatogr. 530:47–55
   PubMedGoogle Scholar
• Barassin S, Saboureau M, Kalsbeek A, et al. (1999). Interindividual differences in the pattern of melatonin secretion of the Wistar rat. J Pineal Res. 27:193–201
   PubMedGoogle Scholar
• Bothorel B, Barassin S, Saboureau M, et al. (2002). In the rat, exogenous melatonin increases the amplitude of pineal melatonin secretion by a direct action on the circadian clock. Eur J Neurosci. 16:1090–8
   PubMed Web of Science ®Google Scholar
• Bourin M, Mocaer E, Porsolt R. (2004). Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: Involvement of melatonin and serotonin receptors. J Psychiatry Neurosci. 29:126–33
   PubMed Web of Science ®Google Scholar
• Chagraoui A, Protais P, Filloux T, Mocaer E. (2003). Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats. Psychopharmacology (Berl). 170:17–22
   PubMed Web of Science ®Google Scholar
• Challet E, Malan A, Pevet P. (1996). Daily hypocaloric feeding entrains circadian rhythms of wheel-running and body temperature in rats kept in constant darkness. Neurosci Lett. 211:1–4
   PubMed Web of Science ®Google Scholar
• Chesworth MJ, Cassone VM, Armstrong SM. (1987). Effects of daily melatonin injections on activity rhythms of rats in constant light. Am J Physiol. 253:R101–7
   Google Scholar
• de Bodinat C, Guardiola-Lemaitre Ba, Mocaër E, et al. (2010). Agomelatine, the first melatonergic antidepressant: Discovery, characterization and development. Nat Rev Drug Discov. 9:628–42
   PubMed Web of Science ®Google Scholar
• Dekeyne A, Mannoury la Cour C, Gobert A, et al. (2008). S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models. Psychopharmacology (Berl). 199:549–68
   PubMed Web of Science ®Google Scholar
• Drijfhout WJ, de Vries JB, Homan EJ, et al. (1999). Novel non-indolic melatonin receptor agonists differentially entrain endogenous melatonin rhythm and increase its amplitude. Eur J Pharmacol. 382:157–66
   PubMed Web of Science ®Google Scholar
• Drijfhout WJ, Grol CJ, Westerink BH. (1993). Microdialysis of melatonin in the rat pineal gland: Methodology and pharmacological applications. J Neurochem. 61:936–42
   PubMedGoogle Scholar
• Graff C, Kohler M, Pévet P, Wollnik F. (2005). Involvement of the retinohypothalamic tract in the photic-like effects of the serotonin agonist quipazine in the rat. Neuroscience. 135:273–83
   PubMed Web of Science ®Google Scholar
• Gunduz B, Stetson MH. (2001). A test of the coincidence and duration models of melatonin action in Siberian hamsters: The effects of 1-hr melatonin infusions on testicular development in intact and pinealectomized prepubertal Phodopus sungorus. J Pineal Res. 30:97–107
   PubMed Web of Science ®Google Scholar
• Herwig A, Pevet P, Bothorel B, et al. (2006). Trans-pineal microdialysis in the Djungarian hamster (Phodopus sungorus): A tool to study seasonal changes of circadian clock activities. J Pineal Res. 40:177–83
   PubMedGoogle Scholar
• Hillegaart V, Ahlenius S. (1994). Time course for synchronization of spontaneous locomotor activity in the rat following reversal of the daylight (12:12 h) cycle. Physiol Behav. 55:73–5
   PubMedGoogle Scholar
• Inouye ST, Kawamura H. (1979). Persistence of circadian rhythmicity in a mammalian hypothalamic “island” containing the suprachiasmatic nucleus. Proc Natl Acad Sci USA. 76:5962–6
   PubMed Web of Science ®Google Scholar
• Kennaway DJ, Moyer RW, Voultsios A, Varcoe TJ. (2001). Serotonin, excitatory amino acids and the photic control of melatonin rhythms and SCN c-FOS in the rat. Brain Res. 897:36–43
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Emsley R. (2006). Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur Neuropsychopharmacol. 16:93–100
   PubMed Web of Science ®Google Scholar
• Krauchi K, Cajochen C, Mori D, et al. (1997). Early evening melatonin and S-20098 advance circadian phase and nocturnal regulation of core body temperature. Am J Physiol. 272:R1178–88
   PubMed Web of Science ®Google Scholar
• Loo H, Dalery J, Macher JP, Payen A. (2003). Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin-agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders. Encephale. 29:165–71
   PubMed Web of Science ®Google Scholar
• Martinet L, Guardiola-Lemaitre B, Mocaer E. (1996). Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent. Pharmacol Biochem Behav 54:713–18
   PubMed Web of Science ®Google Scholar
• Millan MJ, Brocco M, Gobert A, Dekeyne A. (2005). Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: Role of 5-HT2C receptor blockade. Psychopharmacology (Berl). 177:448–58
   PubMed Web of Science ®Google Scholar
• Millan MJ, Gobert A, Lejeune F, et al. (2003). The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther. 306:954–64
   PubMed Web of Science ®Google Scholar
• Moyer RW, Kennaway DJ. (1999). Immunohistochemical localization of serotonin receptors in the rat suprachiasmatic nucleus. Neurosci Lett. 271:147–50
   PubMedGoogle Scholar
• Olie JP, Kasper S. (2007). Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol. 10:661–73
   PubMed Web of Science ®Google Scholar
• Papp M, Gruca P, Boyer PA, Mocaer E. (2003). Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology. 28:694–703
   PubMed Web of Science ®Google Scholar
• Papp M, Litwa E, Gruca P, Mocaer E. (2006). Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. Behav Pharmacol. 17:9–18
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. (1982). The rat brain in stereotaxic coordiantes. New York: Academic press
   Google Scholar
• Perreau-Lenz S, Kalsbeek A, Van Der Vliet J, et al. (2005). In vivo evidence for a controlled offset of melatonin synthesis at dawn by the suprachiasmatic nucleus in the rat. Neuroscience. 130:797–803
   PubMed Web of Science ®Google Scholar
• Pickard GE, Rea MA. (1997). Serotonergic innervation of the hypothalamic suprachiasmatic nucleus and photic regulation of circadian rhythms. Biol Cell. 89:513–23
   PubMed Web of Science ®Google Scholar
• Pitrosky B, Kirsch R, Malan A, et al. (1999). Organization of rat circadian rhythms during daily infusion of melatonin or S20098, a melatonin agonist. Am J Physiol. 277:R812–18
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–29
   PubMed Web of Science ®Google Scholar
• Redman J, Armstrong S, Ng KT. (1983). Free-running activity rhythms in the rat: Entrainment by melatonin. Science. 219:1089–91
   PubMed Web of Science ®Google Scholar
• Redman JR, Francis AJ. (1998). Entrainment of rat circadian rhythms by the melatonin agonist S-20098 requires intact suprachiasmatic nuclei but not the pineal. J Biol Rhythms. 13:39–51
   PubMed Web of Science ®Google Scholar
• Redman JR, Guardiola-Lemaitre B, Brown M, et al. (1995). Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms. Psychopharmacology (Berl). 118:385–90
   PubMed Web of Science ®Google Scholar
• Sage D, Ganem J, Guillaumond F, et al. (2004). Influence of the corticosterone rhythm on photic entrainment of locomotor activity in rats. J Biol Rhythms. 19:144–56
   PubMed Web of Science ®Google Scholar
• Turek FW. (1989). Effects of stimulated physical activity on the circadian pacemaker of vertebrates. J Biol Rhythms. 4:135–47
   PubMed Web of Science ®Google Scholar
• Yamaguchi S, Isejima H, Matsuo T, et al. (2003). Synchronization of cellular clocks in the suprachiasmatic nucleus. Science. 302:1408–12
   PubMed Web of Science ®Google Scholar
• Ying SW, Rusak B, Delagrange P, et al. (1996). Melatonin analogues as agonists and antagonists in the circadian system and other brain areas. Eur J Pharmacol. 296:33–42
   PubMed Web of Science ®Google Scholar
• Yous S, Andrieux J, Howell HE, et al. (1992). Novel naphthalenic ligands with high affinity for the melatonin receptor. J Med Chem. 35:1484–6
   PubMed Web of Science ®Google Scholar